Roche

Tackling Cancer: Breast Cancer's Biggest Current & Upcoming Players
Motley Fool
Tue, 03/12/13 - 05:36 pm
breast cancer
aromatase inhibitors
AstraZeneca
Novartis
Femara
Arimidex
SERMs
Nolvadex
Roche
Herceptin
GSK
Tykerb
Xeloda
Perjeta
Kadcyla
Immunogen
Lymphoseek
Navidea Biopharmaceuticals
Nexavar
ONYX Pharmaceuticals
New anti-inflammatory causes stir at ACC
Pharma Times, UK
Mon, 03/11/13 - 11:00 am
anti-inflammatories
Genmab
Roche
inclacumab
angioplasty
This FDA Approval Is Actually a Big Deal
Motley Fool
Wed, 02/27/13 - 12:40 pm
Kadcyla
Roche
Immunogen
Roche Peels Back The Curtain On Clinical Trial Data
Pharmalot
Wed, 02/27/13 - 12:16 pm
Roche
clinical trials
This Week in Biotech
Motley Fool
Sun, 02/24/13 - 02:20 pm
Roche
Immunogen
Repros Therapeutics
Chelsea Therapeutics
Gilead Sciences
Vivus
FDA OKs Roche drug for late-stage metastatic breast cancer
Reuters
Fri, 02/22/13 - 11:01 am
Roche
metastatic breast cancer
breast cancer
Kadcyla
Italian antitrust agency probes alleged Roche-Novartis cartel
Fierce Pharma
Wed, 02/20/13 - 12:12 pm
Lucentis
Roche
Avastin
Italy
Novartis
antitrust
Roche Alzheimer’s Push May Gain From Obama Brain-Mapping Plan
Bloomberg
Tue, 02/19/13 - 09:39 am
Roche
Alzheimer's disease
Eli Lilly
Brain Activity Map
ImmunoGen, Surprisingly Quiet Ahead Of FDA Decision
Seeking Alpha
Thu, 02/14/13 - 11:17 am
Immunogen
FDA
trastuzumab
Roche
Illumina: Side Stepping Macro Pressure And Delivering In The Long Term
Seeking Alpha
Wed, 02/6/13 - 11:09 am
Illumina
Roche
Life Technologies
How Big Pharma Gets Bigger, And What Little Pharma Can Do About It
Seeking Alpha
Wed, 02/6/13 - 10:12 am
Big Pharma
Novartis
NovaBay Pharmaceuticals
Sanofi
Roche
[video] Roche's CEO on Profit Pipeline
CNBC
Fri, 02/1/13 - 11:02 am
Roche
Roche’s GA101 Met Goals in Stage One of Trial to Replace Rituxan
Bloomberg
Thu, 01/31/13 - 10:41 am
Roche
GA101
Rituxan
chronic lymphocytic leukemia
Roche Sees Sales Growth at Last Year’s Pace on New Drugs
Bloomberg
Wed, 01/30/13 - 11:00 am
Roche
Boehringer Testing Copy of Rituxan in Type of Lymphoma
Bloomberg
Wed, 01/30/13 - 10:57 am
Rituxan
Boehringer Ingelheim
Roche
non-Hodgkin's lymphoma
Statins Beware?
Motley Fool
Mon, 01/28/13 - 12:21 pm
statins
PCSK9 inhibitors
Sanofi
Amgen
Pfizer
Roche
Regeneron
Can Biologics Make You Rich?
Motley Fool
Sun, 01/27/13 - 11:21 am
AbbVie
Amgen
Biogen Idec
JNJ
Roche
This Week in Biotech: Part 2
Motley Fool
Sun, 01/27/13 - 11:20 am
Roche
Novartis
Impax Laboratories
MAP Pharmaceuticals
Allergan
Which Biotech Company Will Be Bought Out Next?
Motley Fool
Sun, 01/27/13 - 11:18 am
Theravance
GSK
Astellas
Vivus
Eli Lilly
Immunogen
Roche
M&A
The Big Gamble of CETP Inhibitors Comment Now Follow Comments
Forbes
Fri, 01/25/13 - 11:05 am
CETP inhibitors
Merck
Anacetrapib
Torcetrapib
Pfizer
Roche
dalceptrapib

Pages